FTLF on Nasdaq
FITLIFE BRANDS, INC.
American medicinal chemicals and botanical products company based in Omaha2
In its 2026 annual report the company says: “The Company distributes the NDS Products principally through franchised General Nutrition Centers, Inc. stores located both domestically and internationally. The Company distributes the MRC Products primarily online through e-commerce platforms, such as Amazon.com, directly to the end consumer.”5 Its shares trade on Nasdaq under the symbol FTLF.2
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with MediWound Ltd., Bon Natural Life Ltd or Charlie's Holdings, Inc., or pick any stock.
- TickerFTLF on Nasdaq2
- IndustryMedicinal Chemicals & Botanical Products2
- HeadquartersOmaha, United States2
- Incorporated inNV3
- Business address5214 S. 136Th Street, Omaha, Ne 681373
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formProfit Corporation2
- LEI549300A8X02SIUSI3V402
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O VCORP SERVICES, LLC, 89701 Carson City, United States2
- Registered withBusiness Center (Secretary of State), E0513582005-72
See how the biggest companies compare on our leaderboards
FitLife Brands, Inc. (the “ Company ”) is a provider of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers marketed under the following brand names: (i) NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, the “ NDS Products ”); (ii) iSatori, BioGenetic Laboratories, and Energize (together, the " iSatori Products "); (iii) Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the “ MRC Products "); (iv) MusclePharm; and (v) Irwin Naturals, Applied Nutrition, and Nature’s Secret (together, the “ Irwin Products ”).5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Regions
United States brought in 95% of the revenue FITLIFE BRANDS, INC. broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| United States | $61.5M | $77.4M |
| Outside the United States | $3.0M | $4.1M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue57¢$9.1M
- Selling, general and admin16¢$2.5M
- Other costs10¢$1.6M
- Income tax4¢$701.0K
- Profit13¢$2.0M
Out of $15.9M in revenue.6
Where each dollar of operating cash went, fiscal 2025
- Capital spending1¢$42.0K
- Kept or used elsewhere99¢$7.4M
Out of $7.4M of cash from operations.7
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $81.5M | $64.5M |
| Cost of goods sold | $50.0M | $36.4M |
| Gross profit | $31.5M | $28.1M |
| Advertising and marketing | $4.9M | $4.6M |
| Selling, general and administrative | $14.0M | $10.0M |
| Merger and acquisition related | $2.1M | $255.0K |
| Depreciation and amortization | $420.0K | $108.0K |
| Total operating expense | $21.4M | $15.0M |
| OPERATING INCOME | $10.1M | $13.1M |
| Interest income | -$98.0K | -$69.0K |
| Interest expense | $1.9M | $1.4M |
| Other expense | $49.0K | $0 |
| Foreign exchange loss (gain) | $19.0K | -$50.0K |
| Total other expense, net | $1.8M | $1.2M |
| INCOME BEFORE INCOME TAX PROVISION | $8.2M | $11.9M |
| PROVISION FOR INCOME TAXES | $1.9M | $2.9M |
| NET INCOME | $6.3M | $9.0M |
| Basic (in dollars per share) | $0.68 | $0.98 |
| Diluted (in dollars per share) | $0.63 | $0.91 |
| Basic weighted average common shares (in shares) | 9.3M shares | 9.2M shares |
| Diluted weighted average common shares (in shares) | 10.0M shares | 9.9M shares |
| Foreign currency translation adjustment | $127.0K | -$370.0K |
| Loss on derivatives | -$26.0K | $0 |
| Comprehensive income | $6.4M | $8.6M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.7
| Period ending | 2025-12-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.6M | $4.5M | ||
| Restricted cash | $0 | $52.0K | ||
| Accounts receivable, net of allowance for credit losses of $9 and $41, respectively | $8.8M | $1.6M | ||
| Inventories, net of allowance for obsolescence of $247 and $100, respectively | $21.3M | $11.1M | ||
| Prepaid expense and other current assets | $1.3M | $923.0K | ||
| Total current assets | $33.1M | $18.1M | ||
| Property and equipment, net | $128.0K | $75.0K | ||
| Right of use asset | $682.0K | $412.0K | ||
| Intangibles, net of amortization of $500 and $152, respectively | $51.4M | $26.2M | ||
| Goodwill | $19.4M | $13.0M | ||
| Deferred tax asset | $1.5M | $644.0K | ||
| Other assets | $83.0K | $0 | ||
| TOTAL ASSETS | $106.3M | $58.5M | ||
| Accounts payable | $6.9M | $4.1M | ||
| Accrued expense | $5.4M | $684.0K | ||
| Income taxes payable | $1.7M | $1.4M | ||
| Product returns | $1.0M | $564.0K | ||
| Term loan current portion | $6.1M | $4.5M | ||
| Lease liability current portion | $433.0K | $81.0K | ||
| Total current liabilities | $21.6M | $11.3M | ||
| Revolving line of credit | $5.6M | $0 | ||
| Term loan, net of current portion and unamortized deferred finance costs | $32.8M | $8.6M | ||
| Long-term lease liability, net of current portion | $272.0K | $331.0K | ||
| Derivative liability | $26.0K | $0 | ||
| Deferred tax liability | $2.3M | $2.2M | ||
| TOTAL LIABILITIES | $62.7M | $22.4M | ||
| Preferred stock, $0.01 par value, 10,000 shares authorized, none outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock, $0.01 par value, 120,000 shares authorized; 9,391 and 9,210 issued and outstanding as of December 31, 2025 and 2024 | $94.0K | $92.0K | ||
| Additional paid-in capital | $32.2M | $31.1M | ||
| Retained earnings | $11.9M | $5.6M | ||
| Accumulated other comprehensive loss | -$561.0K | -$662.0K | ||
| TOTAL STOCKHOLDERS' EQUITY | $43.6M | $36.1M | $27.0M | |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $106.3M | $58.5M | ||
| Allowance of doubtful accounts | $9.0K | $41.0K | ||
| Allowance for obsolescence | $247.0K | $100.0K | ||
| Intangibles amortization | $499.0K | $152.0K | ||
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (in shares) | 10.0M shares | 10.0M shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 120.0M shares | 120.0M shares | 120.0M shares | |
| Common stock, shares issued (in shares) | 9.4M shares | 9.2M shares | ||
| Common stock, shares outstanding (in shares) | 9.4M shares | 9.2M shares |
| Period ending | 2025-12-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.6M | $4.5M | ||
| Restricted cash | $0 | $52.0K | ||
| Accounts receivable, net of allowance for credit losses of $9 and $41, respectively | $8.8M | $1.6M | ||
| Inventories, net of allowance for obsolescence of $247 and $100, respectively | $21.3M | $11.1M | ||
| Prepaid expense and other current assets | $1.3M | $923.0K | ||
| Total current assets | $33.1M | $18.1M | ||
| Property and equipment, net | $128.0K | $75.0K | ||
| Right of use asset | $682.0K | $412.0K | ||
| Intangibles, net of amortization of $500 and $152, respectively | $51.4M | $26.2M | ||
| Goodwill | $19.4M | $13.0M | ||
| Deferred tax asset | $1.5M | $644.0K | ||
| Other assets | $83.0K | $0 | ||
| TOTAL ASSETS | $106.3M | $58.5M | ||
| Accounts payable | $6.9M | $4.1M | ||
| Accrued expense | $5.4M | $684.0K | ||
| Income taxes payable | $1.7M | $1.4M | ||
| Product returns | $1.0M | $564.0K | ||
| Term loan current portion | $6.1M | $4.5M | ||
| Lease liability current portion | $433.0K | $81.0K | ||
| Total current liabilities | $21.6M | $11.3M | ||
| Revolving line of credit | $5.6M | $0 | ||
| Term loan, net of current portion and unamortized deferred finance costs | $32.8M | $8.6M | ||
| Long-term lease liability, net of current portion | $272.0K | $331.0K | ||
| Derivative liability | $26.0K | $0 | ||
| Deferred tax liability | $2.3M | $2.2M | ||
| TOTAL LIABILITIES | $62.7M | $22.4M | ||
| Preferred stock, $0.01 par value, 10,000 shares authorized, none outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock, $0.01 par value, 120,000 shares authorized; 9,391 and 9,210 issued and outstanding as of December 31, 2025 and 2024 | $94.0K | $92.0K | ||
| Additional paid-in capital | $32.2M | $31.1M | ||
| Retained earnings | $11.9M | $5.6M | ||
| Accumulated other comprehensive loss | -$561.0K | -$662.0K | ||
| TOTAL STOCKHOLDERS' EQUITY | $43.6M | $36.1M | $27.0M | |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $106.3M | $58.5M | ||
| Allowance of doubtful accounts | $9.0K | $41.0K | ||
| Allowance for obsolescence | $247.0K | $100.0K | ||
| Intangibles amortization | $499.0K | $152.0K | ||
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (in shares) | 10.0M shares | 10.0M shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 120.0M shares | 120.0M shares | 120.0M shares | |
| Common stock, shares issued (in shares) | 9.4M shares | 9.2M shares | ||
| Common stock, shares outstanding (in shares) | 9.4M shares | 9.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| NET INCOME | $6.3M | $9.0M |
| Depreciation and amortization | $420.0K | $108.0K |
| Allowance for credit losses | -$32.0K | $24.0K |
| Allowance for inventory obsolescence | $147.0K | -$62.0K |
| Stock-based compensation | $404.0K | $459.0K |
| Amortization of deferred financing costs | $40.0K | $41.0K |
| Write-off of deferred financing costs | $49.0K | $0 |
| Amortization of inventory step-up | $1.0M | $0 |
| Accounts receivable - trade | $210.0K | $361.0K |
| Inventories | -$582.0K | -$2.1M |
| Deferred taxes | -$881.0K | $148.0K |
| Prepaid expense and other assets | $200.0K | $692.0K |
| Right-of-use asset | $242.0K | $90.0K |
| Accounts payable | $743.0K | $866.0K |
| Income taxes payable | -$54.0K | $634.0K |
| Lease liability | -$223.0K | -$107.0K |
| Accrued expense and other current liabilities | -$582.0K | -$512.0K |
| Product returns | -$33.0K | -$7.0K |
| Net cash provided by operating activities | $7.4M | $9.6M |
| Purchase of property and equipment | -$42.0K | -$10.0K |
| Net cash used in investing activities | -$42.5M | -$10.0K |
| Proceeds from exercise of stock options | $682.0K | $17.0K |
| Borrowings on term loans | $40.5M | $0 |
| Payoff of 2023 term loans | -$10.9M | $0 |
| Borrowings on line of credit | $5.6M | $0 |
| Net cash provided by (used in) financing activities | $32.1M | -$7.0M |
| Foreign currency impact on cash | $143.0K | $5.0K |
| CHANGE IN CASH AND RESTRICTED CASH | -$2.9M | $2.6M |
| Cash paid for income taxes | $2.4M | $2.5M |
| Cash paid for interest, net of amounts capitalized | $1.7M | $1.4M |
| Addition to right-of-use assets from new operating lease liabilities | $0 | $386.0K |
No quarter-by-quarter statement was filed.
Corporate structure
FITLIFE BRANDS, INC. sits at the top of its group. 6 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of FITLIFE BRANDS, INC.
- ASKELADDEN CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G/A on FITLIFE BRANDS, INC., latest Aug 7, 2026 (3 filings since Jan 17, 2025)
- FITLIFE BRANDS, INC. Omaha, Nebraska, United States
- IN Acquisition Corp. Subsidiary · Nevada, United States
- iSatori, Inc. Subsidiary · Delaware, United States
- Mimi’s Rock GmbH Subsidiary · Germany
- MP Acquisition Corp. Subsidiary · Nevada, United States
- NDS Nutrition Products, Inc. Subsidiary · Florida, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What FITLIFE BRANDS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $869.0K7 Dec 31, 2025 | $964.0K7 Dec 31, 2024 | −9.9% |
| Accumulated depreciation | $741.0K7 Dec 31, 2025 | $889.0K7 Dec 31, 2024 | −16.6% |
| Property and equipment, net | $128.0K7 Dec 31, 2025 | $75.0K7 Dec 31, 2024 | +70.7% |
| Operating-lease assets (leased space) | $682.0K7 Dec 31, 2025 | $412.0K7 Dec 31, 2024 | +65.5% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $19.4M7 Dec 31, 2025 | $13.0M7 Dec 31, 2024 | +48.9% |
| Intangible assets, net (excluding goodwill) | $51.4M7 Dec 31, 2025 | $26.2M7 Dec 31, 2024 | +96.1% |
| Accumulated amortization | $499.0K7 Dec 31, 2025 | $152.0K7 Dec 31, 2024 | +228.3% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $21.3M7 Dec 31, 2025 | $11.1M7 Dec 31, 2024 | +92.6% |
| Raw materials | $2.6M7 Dec 31, 2025 | $826.0K7 Dec 31, 2024 | +209.8% |
| Finished goods | $19.0M7 Dec 31, 2025 | $10.3M7 Dec 31, 2024 | +83.7% |
Properties, in its own words
The Company, including its subsidiaries, leases its headquarters in Omaha, Nebraska, as well as office space in Culver City, California. The Company previously leased office space in Oakville, Ontario, Canada; this lease expired in January 2026 and was not renewed as part of the Company’s ongoing optimization of its operating footprint. Management believes that the Company's locations are adequate to support the business and suitable for present purposes, and the property and equipment have been well maintained.
Item 2 of the 10-K filed Mar 31, 2026.5
Leadership
Who has led FITLIFE BRANDS, INC., and when. Pick a name to see everywhere that person has worked.
President
Chief financial officer
- Chief executive officerJudd Dayton Mar 22, 2018 to now15
- Chief executive officerStephen D. Adele Feb 18, 2016 to Feb 18, 201616
- Chief executive officerJohn S. Wilson Sep 1, 2010 to Feb 25, 201517
- PresidentRyan P. Hansen May 19, 2026 to now18
- Chief financial officerJakob York Aug 15, 2022 to now19
- Chief financial officerSusan Kinnaman Feb 25, 2019 to Apr 20, 202120
- Chief financial officerMichael S. Abrams Aug 30, 2010 to Feb 14, 201721
Board members and other officers (15)
- Executive Vice PresidentRyan P. Hansen May 12, 2025 to now22
- Chief Retail OfficerPatrick John Phillip Ryan Jan 11, 2023 to Jun 4, 202423
- Board memberShannon K. Pappas May 12, 2025 to now24
- Board memberMatthew Lingenbrink Aug 14, 2024 to now25
- Board memberJudd Dayton Jun 30, 2017 to now26
- Board memberStephen D. Adele Feb 18, 2016 to Feb 18, 201616
- Board memberSeth Yakatan Oct 19, 2015 to now27
- Board memberTodd Ordal Oct 19, 2015 to now28
- Board memberGrant Robert Dawson Nov 8, 2013 to now29
- Board memberFadi M. Aramouni Dec 5, 2013 to Oct 21, 201530
- Board memberLewis Jaffe Jan 13, 2011 to Oct 20, 202031
- Board memberMichael S. Abrams Mar 30, 2011 to Feb 14, 201732
- Board memberJohn S. Wilson Sep 1, 2010 to Feb 25, 201517
- Board memberElorian Connard Landers Sep 13, 2010 to Jan 3, 201133
- Board memberScott D. Landow Nov 24, 2010 to Nov 24, 201034
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- IN Acquisition Corp. Nevada4
- MP Acquisition Corp. Nevada4
- Mimi’s Rock GmbH Germany4
- Mimi’s Rock, Inc. Canada4
- NDS Nutrition Products, Inc. Florida4
- iSatori, Inc. Delaware4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- BOND LABORATORIES, INC.Sep 7, 2006 to Oct 1, 20133
Timeline
- Sep 9, 20268-K Regulation FD disclosure35
- Aug 13, 20268-K Results of operations; Shareholder vote; Regulation FD disclosure36
- May 22, 20268-K Executive or director change37
- May 14, 20268-K Results of operations; Regulation FD disclosure38
- Apr 7, 20268-K Regulation FD disclosure39
- Apr 1, 20268-K Results of operations; Regulation FD disclosure40
- Dec 10, 20258-K Regulation FD disclosure41
- Nov 13, 20258-K Results of operations; Regulation FD disclosure42
- Oct 20, 20258-K Financial statements and exhibits43
- Aug 19, 20258-K Regulation FD disclosure44
- Aug 14, 20258-K Results of operations; Regulation FD disclosure45
- Aug 13, 20258-K Shareholder vote46
- Mar 22, 2018New chief executive Judd Dayton becomes CEO15
- Feb 18, 2016New chief executive Stephen D. Adele becomes CEO16
- Sep 1, 2010New chief executive John S. Wilson becomes CEO17
- Jul 26, 2005Founded FITLIFE BRANDS, INC. is founded2
Calendar
Coming up
- Nov 12, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.19 a share, on Nov 13, 2025.47
When it reported results
- Aug 13, 2026Reported quarterly or annual results36
- May 14, 2026Reported quarterly or annual results38
- Apr 1, 2026Reported quarterly or annual results40
- Nov 13, 2025Reported quarterly or annual results42
- Aug 14, 2025Reported quarterly or annual results45
- May 15, 2025Reported quarterly or annual results48
- Mar 27, 2025Reported quarterly or annual results49
- Mar 13, 2025Reported quarterly or annual results50
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
123 filings to the SEC since October 2021: 10 annual reports, 15 quarterly reports, 47 major events, 30 insider forms, 3 large holders, 18 other. The latest 20:
- Sep 9, 20268-K EDGAR
- Sep 2, 20264 EDGAR
- Aug 21, 20264 EDGAR
- Aug 13, 20268-K EDGAR
- Aug 13, 202610-Q EDGAR
- Aug 7, 2026SCHEDULE 13G/A EDGAR
- Jun 26, 2026DEFA14A EDGAR
- Jun 26, 2026DEFA14A EDGAR
- Jun 26, 2026DEF 14A EDGAR
- May 22, 20268-K EDGAR
- May 19, 20264 EDGAR
- May 14, 20268-K EDGAR
- May 14, 202610-Q EDGAR
- Apr 21, 202610-K/A EDGAR
- Apr 20, 20264 EDGAR
- Apr 20, 20265 EDGAR
- Apr 14, 20264 EDGAR
- Apr 14, 20264 EDGAR
- Apr 7, 20268-K EDGAR
- Apr 1, 20268-K EDGAR
The 123 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
15 open-market trades by officers, directors and large owners since October 2021: 12 buys and 3 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Pappas Shannon K.Director | Buy | 1,000 | $10.25 | $10.2K | Form 4 |
| Apr 10, 2026 | Lingenbrink MatthewDirector | Buy | 3,000 | $9.76 | $29.3K | Form 4 |
| Apr 10, 2026 | Dawson Grant RobertDirector | Buy | 3,000 | $9.98 | $29.9K | Form 4 |
| Jan 15, 2026 | Yakatan SethDirector | Buy | 164 | $15.36 | $2.5K | Form 4 |
| Dec 15, 2025 | Yakatan SethDirector | Buy | 139 | $18.31 | $2.5K | Form 4 |
| Sep 15, 2025 | Yakatan SethDirector | Buy | 142 | $17.87 | $2.5K | Form 4 |
| Aug 25, 2025 | Yakatan SethDirector | Buy | 148 | $17.00 | $2.5K | Form 4 |
| Apr 15, 2025 | Ordal ToddDirector | Buy | 300 | $12.07 | $3.6K | Form 4 |
| Apr 14, 2025 | Lingenbrink MatthewDirector | Buy | 3,000 | $12.17 | $36.5K | Form 4 |
| Mar 31, 2025 | Lingenbrink MatthewDirector | Buy | 2,800 | $12.17 | $34.1K | Form 4 |
| Jan 15, 2025 | Ordal ToddDirector | Buy | 150 | $30.37 | $4.6K | Form 4 |
| Jun 3, 2024 | Ryan Patrick John PhillipCHIEF RETAIL OFFICER | Sale | 6,544 | $32.29 | $211.3K | Form 4 |
| May 31, 2024 | Ryan Patrick John PhillipCHIEF RETAIL OFFICER | Sale | 4,000 | $31.00 | $124.0K | Form 4 |
| Dec 15, 2023 | Ryan Patrick John PhillipCHIEF RETAIL OFFICER | Sale | 4,000 | $24.50 | $98.0K | Form 4 |
| May 18, 2023 | York JakobCHIEF FINANCIAL OFFICER | Buy | 1,000 | $17.00 | $17.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- ASKELADDEN CAPITAL MANAGEMENT LLCSCHEDULE 13G/A, 3 filings Jan 17, 2025 to Aug 7, 202651
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Dayton Judd | 54 | $418.8K | $598.8K52 |
| 2025 | Ryan Hansen | 38 | $266.0K | $346.5K52 |
| 2025 | Jakob York | 49 | $233.1K | $318.3K52 |
| 2024 | Chief Executive Officer and Chair of the Board | $398.0K | $578.0K52 | |
| 2024 | Executive VicePresident | $253.7K | $303.7K52 | |
| 2024 | Chief Financial Officer | $219.6K | $293.8K52 |
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- PPP loans $449.7K
Figures by year
| Year | PPP loans | Total |
|---|---|---|
| 2020 | $449.7K | $449.7K |
PPP loans
Paycheck Protection Program loans of $150,000 and up, approved April 2020 to July 2021, from the SBA53. Matched to this company by name and state.
- Apr 27, 2020$449.7K PPP loan (first draw) from OneWest Bank, A Division of First-Citizens Bank and Trust Company53To FITLIFE BRANDS, INC., Omaha NE; $453.0K forgiven Jan 19, 2021
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 42. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How FITLIFE BRANDS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARFITLIFE BRANDS, INC.1
- CIK0001374328
- Employer ID (EIN)20-34643835
- Filer statusNon–accelerated filer not an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inNevada5
- Fiscal year endsDecember 311
- Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address5214 S. 136Th Street, Omaha, NE 681371
- Phone402-884-18941
- Shares outstanding9,391,072 as of Aug 12, 202614
- Public float$50.7M as of Jun 30, 20255
- AuditorWeinberg & Company, P.A., Los Angeles, California PCAOB ID 572; no auditor attestation of internal control over financial reporting5
- On EDGAR sinceSep 7, 20061
- Filings539 in all: 8-K (151), 4 (140), 10-Q (56), SC 13G/A (22), 3 (19), 10-K (18), DEF 14A (11), UPLOAD (11)1
All 44 form types
CORRESP (10), 5 (9), 10-K/A (7), NT 10-K (7), SC 13D/A (7), SC 13G (7), 4/A (6), 425 (6), NT 10-Q (6), DEFA14A (5), SB-2/A (4), 10QSB (3), D (3), EFFECT (3), 10KSB (2), 424B3 (2), 8-K/A (2), PRE 14A (2), S-8 (2), SCHEDULE 13G/A (2), 10KSB/A (1), 10QSB/A (1), 15-12G (1), 15-12G/A (1), 3/A (1), 8-A12B (1), 8-A12G (1), CERT (1), PRER14A (1), REGDEX (1), S-3 (1), S-4 (1), S-4/A (1), SB-2 (1), SC 13D (1), SCHEDULE 13G (1)
- Latest filingsAnnual report (10-K) Mar 31, 2026
Quarterly report (10-Q) Aug 13, 2026
Proxy statement (DEF 14A) Jun 26, 2026
Latest 8-K (8-K) Sep 9, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.01 per share | FTLF | Nasdaq |
From the cover page of the 10-K filed Mar 31, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks FITLIFE BRANDS, INC. names in Item 1A of its 10-K filed Mar 31, 2026: 40 risks under these headings, as written.5
- We face significant competition in the markets in which we compete. If we are not able to compete effectively, we may not be able to increase sales or maintain profitability.
- A substantial portion of our revenue is from sales of products on Amazon’s U.S. Marketplace and any change, limitation or restriction on our ability to operate on Amazon’s platform could have a material adverse effect on our business, results of operations, financial condition and prospects.
- We are currently dependent on sales to GNC for a substantial portion of our sales.
- Loss of, a significant reduction of purchases by, or bankruptcy of a major distribution partner or customer, may adversely affect our business, financial condition, results of operations and cash flows.
- Our ability to materially increase sales is largely dependent on the ability to increase sales of product to our wholesale partners as well as directly to the end consumer. We may invest significant amounts in these expansions with little success, and if we are unable to maintain good relationships with our existing customers and e-commerce platforms, our business could suffer.
- We must identify changing consumer and customer preferences and behaviors and develop and offer products to meet these preferences.
- Our intellectual property rights are valuable and any inability to protect them could reduce the value of our products and brands and have a material adverse effect on our business.
- Our results may be adversely impacted if consumers do not maintain favorable perceptions of our brands.
- Our sales and profit growth are dependent upon our ability to expand existing market penetration and enter into new markets.
- We are currently dependent on a limited number of independent suppliers and manufacturers of our products, which may affect our ability to deliver our products in a timely manner. If we are not able to ensure timely product deliveries, potential distributors and customers may not order our products, and our revenue may decrease.
- Adverse publicity associated with our products, ingredients, or those of similar companies, could adversely affect our sales and revenue.
- The efficacy of nutritional supplement products is supported by limited conclusive clinical studies, which could result in reduced market acceptance of these products and lower revenue or lower revenue growth rates.
The other 28 risks
- If the products we sell do not have the healthful effects intended, our business may suffer.
- A slower growth rate in the nutritional supplement industry could lead to reduced revenue or make it more difficult for us to sustain consistent revenue growth.
- Future outbreaks of COVID-19 or other illnesses could have a material adverse impact on us in the future.
- Our success depends on the experience and skill of our chief executive officer and key personnel, whom we may not be able to retain and we may not be able to hire enough additional personnel to meet our needs.
- We are currently a smaller reporting company. If we become an accelerated filer, we will be required to obtain an auditor attestation on our internal control over financial reporting.
- The Company was profitable during the years ended December 31, 2025 and 2024. However, we may not be able to achieve sustained profitability. Our failure to sustain profitability or effectively manage growth could result in net losses, and therefore negatively affect our financial condition.
- We may not be able to effectively manage our growth, which could materially harm our business, financial condition, results of operations and cash flows.
- Unfavorable economic conditions, including high inflation, recessions and other macroeconomic conditions or trends may have an adverse impact on our business, financial results, and prospects.
- Trade policies, treaties and tariffs could have a material adverse effect on our business.
- We have incurred substantial debt in conjunction with our acquisitions and may incur additional debt in connection with our M&A strategy, which could have a negative impact on our liquidity position and which could adversely affect our business.
- The agreements governing our current and potential future indebtedness may contain various covenants that limit our ability to take certain actions and also require us to meet financial maintenance tests, and failure to comply with these covenants could have a material adverse effect on us.
- To service indebtedness and fund other cash needs, we will require a significant amount of cash. Our ability to generate cash depends on many factors beyond our control.
- Increases in interest rates may negatively affect our earnings.
- Impairment in the carrying value of intangible assets could negatively impact our financial condition and results of operations. If our goodwill or other intangible assets become impaired, we will be required to record impairment charges, which may be significant.
- Unsuccessful implementation of business strategies to reduce costs, or unintended consequences of the implementation of such strategies, may adversely affect our business, financial condition, results of operations and cash flows.
- We are affected by extensive laws, governmental regulations, administrative determinations, court decisions and similar constraints, which can make compliance costly and subject us to enforcement actions by governmental agencies.
- We are dependent on our third-party manufacturers to supply our products in the compositions we require, and we do not independently analyze each production lot of our products. Any errors in our product manufacturing could result in product recalls, significant legal exposure, and reduced revenue.
- Certain of our products are subject to a higher level of regulatory scrutiny, resulting in increased costs of operations and the potential for delays in product sales.
- Pending and future litigation and claims may impair our reputation or lead us to incur significant costs.
- Our products may not meet health and safety standards or could become contaminated.
- If our products become contaminated or adulterated, or if they are misbranded or mislabeled, we might need to recall or withdraw those items and we may experience product liability claims.
- If we pursue additional acquisitions or other strategic transactions, we may not be able to successfully consummate favorable transactions or successfully integrate acquired businesses.
- If we fail to comply with the continued listing requirements of the Nasdaq Capital Market, our Common Stock may be delisted and the price of our Common Stock and our ability to access the capital markets could be negatively impacted.
- The price of our securities could be subject to wide fluctuations and your investment could decline in value.
- We may issue Preferred Stock with rights senior to the Common Stock.
- You should not rely on an investment in our Common Stock for the payment of cash dividends.
- Our Chair of the Board of Directors, Chief Executive Officer and significant shareholder may have certain personal interests that may affect the Company.
- Compliance with changing corporate governance regulations and public disclosures may result in additional risks and exposures.
Legal proceedings
We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or any of its subsidiaries, threatened against or affecting the Company, our Common Stock, any of our subsidiaries or of the Company’s or our subsidiaries’ directors or officers in their capacities as such, in which an adverse decision could have a material adverse effect.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARJudd Dayton, Chief executive officer
- 16
- 17
- 18SEC EDGARRyan P. Hansen, President
- 19SEC EDGARJakob York, Chief financial officer
- 20
- 21
- 22
- 23
- 24SEC EDGARShannon K. Pappas, Board member
- 25SEC EDGARMatthew Lingenbrink, Board member
- 26SEC EDGARJudd Dayton, Board member
- 27SEC EDGARSeth Yakatan, Board member
- 28SEC EDGARTodd Ordal, Board member
- 29SEC EDGARGrant Robert Dawson, Board member
- 30SEC EDGARFadi M. Aramouni, Board member
- 31SEC EDGARLewis Jaffe, Board member
- 32SEC EDGARMichael S. Abrams, Board member
- 33
- 34SEC EDGARScott D. Landow, Board member
- 35SEC EDGARRegulation FD disclosure
- 36
- 37SEC EDGARExecutive or director change
- 38
- 39SEC EDGARRegulation FD disclosure
- 40
- 41SEC EDGARRegulation FD disclosure
- 42
- 43SEC EDGARFinancial statements and exhibits
- 44SEC EDGARRegulation FD disclosure
- 45
- 46SEC EDGARShareholder vote
- 47NasdaqNasdaq calendar
- 48
- 49
- 50
- 51
- 52
- 53